Copay help by condition · Cancer and blood cancer · read 2026-11-10
Chronic Myeloid Leukemia: which charitable copay funds are open
All 5 funds we hold for Chronic Myeloid Leukemia are closed or at capacity right now (read 2026-11-10).
Funds fill and reopen. Use the alert below, ask the manufacturer's program for your drug (see the assistance finder), and check your state's Medicaid coverage.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Chronic Myeloid Leukemia
- WaitlistChronic Myeloid Leukemia
Accessia Health ·
Award level: not statedInsurance supported: not stated
The program page lists the program as At Capacity, Waitlist Open. Its tracks: privately insured track waitlist open (at capacity); publicly insured track waitlist open (at capacity). It shows no date. Source page
- Closed or at capacityChronic Myeloid Leukemia
Blood Cancer United (formerly the Leukemia and Lymphoma Society) ·
Award level: $8,000Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Soliciting Funding, which its own text defines as at maximum capacity and not enrolling new or renewal patients; no waitlist is kept. Source page
- Closed or at capacityChronic Myeloid Leukemia
CancerCare ·
Award level: not statedInsurance supported: not stated
The page marks the fund as not currently open for new enrollments (the fund row's own data-statuses attribute reads closed). Source page
- Closed or at capacityChronic Myeloid Leukemia
Good Days ·
Award level: not statedInsurance supported: not stated
The page marks the fund as not currently open for new enrollments (the fund's list item on the page carries the class closed). Source page
- Closed or at capacityChronic Myeloid Leukemia - Medicare Access
HealthWell Foundation ·
Award level: not statedInsurance supported: not stated
The page lists the fund as Closed. Source page
Drugs whose FDA label names Chronic Myeloid Leukemia
4 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 2 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Scemblix Asciminib Hydrochloride Every route for this drug | Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). Label on openFDA, read 2026-11-10 | Novartis Patient Assistance Foundation (NPAF) (program page) | not in the CMS negotiated-price file |
| Sprycel Dasatinib Every route for this drug | Dasatinib tablets are indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. Label on openFDA, read 2026-11-10 | Bristol Myers Squibb Patient Assistance Foundation (program page) | not in the CMS negotiated-price file |
| Tasigna Nilotinib Hcl | Adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
| Iclusig Ponatinib Hcl | Chronic Myeloid Leukemia (CML) Chronic phase (CP) CML with resistance or intolerance to at least two prior kinase inhibitors. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Funds for costs around Chronic Myeloid Leukemia
These pay for a kind of cost, not a diagnosis. Each is shown with its own status.
Funds for costs around cancer and blood cancer in general: behavioral health (1 open of 2), caregiver support (0 open of 2), clinical trial costs (0 open of 1), home care (1 open of 1), named fund (0 open of 1), pain management (0 open of 1), testing (1 open of 1) and transportation (0 open of 1). Every one is listed, with its source, on the Cancer and blood cancer page.
Related conditions
No broader or more specific condition page for this one.
Group: Cancer and blood cancer. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-10. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: chronic-myeloid-leukemia.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Chronic Myeloid Leukemia?
As read on 2026-11-10, none of the 5 funds we hold for Chronic Myeloid Leukemia say they are open. Funds reopen, so use the alert on this page.
Which organizations run funds for Chronic Myeloid Leukemia?
Accessia Health, Blood Cancer United (formerly the Leukemia and Lymphoma Society), CancerCare, Good Days and HealthWell Foundation. Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-10). We do not promise a fund is still in that state today.